072 Impact of telehealth on multiple sclerosis (MS) outpatient clinics during the COVID-19 pandemic. (23rd August 2021)
- Record Type:
- Journal Article
- Title:
- 072 Impact of telehealth on multiple sclerosis (MS) outpatient clinics during the COVID-19 pandemic. (23rd August 2021)
- Main Title:
- 072 Impact of telehealth on multiple sclerosis (MS) outpatient clinics during the COVID-19 pandemic
- Authors:
- Li, Vivien
Nguyen, Ai-Lan
Roos, Izanne
Buzzard, Katherine
Dwyer, Chris
Marriott, Mark
Monif, Mastura
Malpas, Charles
Roberts, Stefanie
Taylor, Lisa
Carle, Elizabeth
Taylor, Nicola
Tunnell, Kelsey
Kilpatrick, Trevor
Kalincik, Tomas - Abstract:
- Abstract : Objectives: Characterise telehealth use in MS clinics during the COVID–19 pandemic. Assess patient and clinician attitudes towards telehealth. Compare telehealth–based and physical EDSS obtained during period of telehealth implementation. Methods: Clinic records from Mar-Dec 2020 were reviewed. Patients and clinicians completed questionnaires about experiences using Telehealth. The iMed database was searched for EDSS recorded via face-to-face and telehealth appointments during and compared to face-to-face EDSS preceding and following the study period. T-test and Chi-square test were used for between-group comparisons. Results: 2023 appointments (27% face-to-face, 35% video, 37% telephone) were conducted. New referrals were predominantly face-to-face (66%). 89% of patients were satisfied with telehealth. 58% felt they were as good as face-to-face visits, whilst only 11% of clinicians agreed. Many patients favoured a hybrid model. Safety during the COVID-19 pandemic was important to both groups. EDSS increase from the preceding visit was recorded in a significantly higher proportion of face-to-face than telehealth appointments (p=0.027), with the increase driven by patients with baseline EDSS≤4.0. Amongst patients with EDSS increases, similar numbers of suspected relapses were seen via both modalities. Absolute increase in EDSS was also significantly greater amongst patients seen face-to-face (p<0.0001). There was no significant difference in EDSS change atAbstract : Objectives: Characterise telehealth use in MS clinics during the COVID–19 pandemic. Assess patient and clinician attitudes towards telehealth. Compare telehealth–based and physical EDSS obtained during period of telehealth implementation. Methods: Clinic records from Mar-Dec 2020 were reviewed. Patients and clinicians completed questionnaires about experiences using Telehealth. The iMed database was searched for EDSS recorded via face-to-face and telehealth appointments during and compared to face-to-face EDSS preceding and following the study period. T-test and Chi-square test were used for between-group comparisons. Results: 2023 appointments (27% face-to-face, 35% video, 37% telephone) were conducted. New referrals were predominantly face-to-face (66%). 89% of patients were satisfied with telehealth. 58% felt they were as good as face-to-face visits, whilst only 11% of clinicians agreed. Many patients favoured a hybrid model. Safety during the COVID-19 pandemic was important to both groups. EDSS increase from the preceding visit was recorded in a significantly higher proportion of face-to-face than telehealth appointments (p=0.027), with the increase driven by patients with baseline EDSS≤4.0. Amongst patients with EDSS increases, similar numbers of suspected relapses were seen via both modalities. Absolute increase in EDSS was also significantly greater amongst patients seen face-to-face (p<0.0001). There was no significant difference in EDSS change at subsequent follow-up in patients with consecutive face-to-face versus intervening telehealth appointments. Conclusion: Patient satisfaction with telehealth was high, whilst clinicians preferred face-to-face consultations. EDSS increase was more frequently recorded via face-to-face than telehealth appointments, which may underestimate lower EDSS. Future clinics could combine both modalities. … (more)
- Is Part Of:
- BMJ neurology open. Volume 3(2021) Supplement 1
- Journal:
- BMJ neurology open
- Issue:
- Volume 3(2021) Supplement 1
- Issue Display:
- Volume 3, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 3
- Issue:
- 1
- Issue Sort Value:
- 2021-0003-0001-0000
- Page Start:
- A26
- Page End:
- A27
- Publication Date:
- 2021-08-23
- Subjects:
- Neurology -- Periodicals
616.8 - Journal URLs:
- https://neurologyopen.bmj.com/ ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/bmjno-2021-ANZAN.72 ↗
- Languages:
- English
- ISSNs:
- 2632-6140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26363.xml